Chester Stanley Zygmont III

CIK: 0001900657

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REVB

REVELATION BIOSCIENCES, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

REVB
REVELATION BIOSCIENCES, INC.
Aug 17, 2026
Award(A)
Direct
208.1K shares-
REVB
REVELATION BIOSCIENCES, INC.
Aug 17, 2026
Gift(G)
Indirect
208.1K shares-
REVB
REVELATION BIOSCIENCES, INC.
Aug 17, 2026
Gift(G)
Direct
208.1K shares-
REVB
REVELATION BIOSCIENCES, INC.
Apr 30, 2026
Tax Payment(F)
Indirect
13.3K shares at avg. $1.10$15K
REVB
REVELATION BIOSCIENCES, INC.
Feb 4, 2026
Tax Payment(F)
Indirect
13.1K shares at avg. $1.65$22K
REVB
REVELATION BIOSCIENCES, INC.
Jan 8, 2026
Award(A)
Indirect
78.1K shares at avg. $0.90$70K
REVB
REVELATION BIOSCIENCES, INC.
Oct 29, 2025
Award(A)
Indirect
390.6K shares at avg. $1.28$500K
REVB
REVELATION BIOSCIENCES, INC.
Feb 11, 2025
Award(A)
Indirect
15K shares at avg. $3.87$58K

		Type	Shares	Price		Ownership
Aug 17, 2026	REVB REVELATION BIOSCIENCES, INC.	Award(A)	208,073	-	$0	Direct
Aug 17, 2026	REVB REVELATION BIOSCIENCES, INC.	Gift(G)	208,073	-	$0	Indirect
Aug 17, 2026	REVB REVELATION BIOSCIENCES, INC.	Gift(G)	208,073	-	$0	Direct
Apr 30, 2026	REVB REVELATION BIOSCIENCES, INC.	Tax Payment(F)	13,285	$1.10	$14,614	Indirect
Feb 4, 2026	REVB REVELATION BIOSCIENCES, INC.	Tax Payment(F)	13,100	$1.65	$21,615	Indirect
Jan 8, 2026	REVB REVELATION BIOSCIENCES, INC.	Award(A)	78,145	$0.90	$70,331	Indirect
Oct 29, 2025	REVB REVELATION BIOSCIENCES, INC.	Award(A)	390,614	$1.28	$499,986	Indirect
Feb 11, 2025	REVB REVELATION BIOSCIENCES, INC.	Award(A)	15,048	$3.87	$58,236	Indirect

1-8 of 8 transactions

About Zygmont Chester Stanley III

Zygmont Chester Stanley III (SEC CIK 0001900657) files insider reports with the SEC as Chief Financial Officer of REVELATION BIOSCIENCES, INC. (REVB).

Signal8 holds 6 ownership filings by Zygmont Chester Stanley III, all Form 4s, filed between Feb 13, 2025 and Aug 18, 2026. Those filings report 8 transactions, from Feb 11, 2025 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Zygmont Chester Stanley III's filings is in SAN DIEGO, CA.

Recent filings by Zygmont Chester Stanley III

Aug 17, 2026: Grant or award of REVB shares (Form 4, code A).
Aug 17, 2026: Gifts of REVB shares (2 lines, Form 4, code G).
Apr 30, 2026: Tax withholding of REVB shares (Form 4, code F).
Feb 4, 2026: Tax withholding of REVB shares (Form 4, code F).
Jan 8, 2026: Grant or award of REVB shares (Form 4, code A).

Other insiders filing for REVELATION BIOSCIENCES, INC. (REVB)

Rolke James, Chief Executive Officer
Chawla Lakhmir S, Director
ROPER JESS, Director
CARVER JENNIFER, Director
TIDMARSH GEORGE F, Director

How to read Form 4 transaction codes